Skip to content
Baret News – Lifestyle
Author:
ABBOTT LABORATORIES
Abbott secures CE Mark for world’s first dual glucose-ketone sensing technology for people with diabetes
May 27, 2026
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening
May 27, 2026
Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
April 28, 2026
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
April 25, 2026